Jupiter Targets Multi-Vascular Expansion, Raises Over $40M To Advance SPIRARE II

The Series B Funding Will Support Pivotal Trials, FDA Submission And Initial Commercial Rollout

Vertex differentiates with fixation technology allowing single-device navigation and precision. Picture Credit: Jupiter Endovascular

More from Financing

More from Business